Abstract:BACKGROUND & AIMS:By binding to T cell immunoglobulin mucin-3 (TIM-3) on activated Th1 cells, galectin-9 (Gal-9) negatively regulates Th1-type alloimmunity. Although T cells contribute to hepatic ischemia-reperfusion injury (IRI), it is unknown whether negative T cell-dependent TIM-3 co-stimulation may rescue IR-stressed orthotopic liver transplants from innate immunity-driven inflammation. METHODS:We used wild type (WT) and TIM-3 transgenic (Tg) mice (C57BL/6) as liver donors and recipients in a clinically-relevant model of hepatic cold storage (20 h at 4°C in UW solution) and syngeneic orthotopic liver transplantation (OLT). RESULTS:Orthotopic liver transplants in WT or TIM-3Tg→TIM-3Tg groups were resistant against IR-stress, evidenced by preserved hepatocellular function (serum ALT levels) and liver architecture (Suzuki's score). In contrast, orthotopic liver transplants in WT or TIM-3Tg→WT groups were susceptible to IRI. TIM-3 induction in circulating CD4+ T cells of the recipient: (1) depressed T-bet/IFN-γ, while amplifying GATA3 and IL-4/IL-10 expression in orthotopic liver transplants; (2) promoted T cell exhaustion (PD-1, LAG-3) phenotype; and (3) depressed neutrophil and macrophage infiltration/function in orthotopic liver transplants. In parallel studies, we documented for the first time that Gal-9, a natural TIM-3 ligand, was produced primarily by and released from IR-stressed hepatocytes, both in vivo and in vitro. Moreover, exogenous recombinant Gal-9 (rGal-9) potentiated liver resistance against IRI by depressing T cell activation and promoting apoptosis of CD4+ T cells. CONCLUSIONS:Harnessing TIM-3/Gal-9 signalling at the T cell-hepatocyte interface facilitates homeostasis in IR-stressed orthotopic liver transplants. Enhancing anti-oxidant hepatocyte Gal-9 potentiates liver IR-resistance. Negative regulation by recipient TIM-3+CD4+ cells provides evidence for cytoprotective functions of a discrete T cell subset, which should be spared when applying T cell-targeted immunosuppression in transplant recipients.

Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection

Increasing LAG-3 Expression Suppresses T-cell Function in Chronic Hepatitis B

T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection

Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication

Expression of Tim-3 in peripheral CD8 + T cells and its significance in patients with chronic hepatitis B

Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection

T Cell Immunoglobulin- and Mucin-Domain-containing Molecule-3 (Tim-3) Mediates Natural Killer Cell Suppression in Chronic Hepatitis B.

HCV‐infected Hepatocytes Drive CD4+CD25+Foxp3+ Regulatory T‐cell Development Through the Tim‐3/Gal‐9 Pathway

Blockade of Tim-3 Pathway Ameliorates Interferon-γ Production from Hepatic CD8+ T Cells in a Mouse Model of Hepatitis B Virus Infection

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

Blockade of Tim‐3 Signaling Restores the Virus‐specific CD8+T‐cell Response in Patients with Chronic Hepatitis B

MicroRNA‐155 Regulates Interferon‐γ Production in Natural Killer Cells Via Tim‐3 Signalling in Chronic Hepatitis C Virus Infection

The Relationship Between Tim-3 and the Ligand Galectin-9 and Virus Infection

[Expression and Significance of Tim-3 on Peripheral Blood Monocytes in Patients with Chronic Hepatitis B].

Monoclonal antibody against human Tim-3 enhances antiviral immune response

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.

Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Association Of T-Cell Immunoglobulin And Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms With Susceptibility And Disease Progression Of Hbv Infection

Impaired Toll-Like Receptor 3-Mediated Immune Responses from Macrophages of Patients Chronically Infected with Hepatitis C Virus

Tim-3 promotes viral infection by suppressing USP25-TRAF3-IRF7 signaling pathway